Literature DB >> 11374665

Retreatment of Helicobacter pylori infection after initial treatment failure.

D J Kearney1.   

Abstract

OBJECTIVES: Helicobacter pylori treatment regimens fail to cure the infection in at least 10-20% of patients undergoing initial treatment. Retreatment strategies for patients who have failed initial treatment for H. pylori infection remain poorly described.
METHODS: The literature describing the frequency of H. pylori treatment failure and factors leading to failure is reviewed. The role of antibiotic resistance is discussed and clinical studies assessing success rates according to antibiotic resistance are described. Clinical trials evaluating the treatment success rates for a second episode of treatment are discussed.
RESULTS: The literature describing retreatment of failed H. pylori infection remains limited. The existing data support the use of bismuth-based quadruple therapy or ranitidine bismuth citrate (RBC)-based triple therapy as the preferred agents after initial treatment failure.
CONCLUSION: Further studies are needed to better define the optimal second treatment regimen after failed H. pylori treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11374665     DOI: 10.1111/j.1572-0241.2001.03788.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

1.  Management of Helicobacter pylori infection. Treatment of ulcers can be improved and over-reliance on proton pump inhibitors reduced.

Authors:  Ian L P Beales; Helena K Parsons; David S Sanders; Martyn J Carter; Alan J Lobo; Trevor Watts
Journal:  BMJ       Date:  2002-03-09

2.  Second-line rescue therapy of helicobacter pylori infection.

Authors:  Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

Review 3.  "Rescue" regimens after Helicobacter pylori treatment failure.

Authors:  Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

4.  Presence and density of Helicobacter pylori biofilms in human gastric mucosa in patients with peptic ulcer disease.

Authors:  James M Coticchia; Choichi Sugawa; Vivian R Tran; Jose Gurrola; Evan Kowalski; Michael A Carron
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

5.  Identification of Helicobacter pylori biofilms in human gastric mucosa.

Authors:  Michael A Carron; Vivian R Tran; Choichi Sugawa; James M Coticchia
Journal:  J Gastrointest Surg       Date:  2006-05       Impact factor: 3.452

6.  Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection.

Authors:  Zeki Mesut Yalin Kiliç; Aydin Seref Köksal; Başak Cakal; Işilay Nadir; Yasemin Ozderin Ozin; Sedef Kuran; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

7.  Efficacy of the Combination of Tetracycline, Amoxicillin, and Lansoprazole in the Eradication of Helicobacter pylori in Treatment-Naïve Patients and in Patients Who Are Not Responsive to Clarithromycin-Based Regimens: A Pilot Study.

Authors:  Mesut Sezikli; Züleyha Akkan Cetinkaya; Fatih Güzelbulut; Atakan Yeşil; Mustafa Erhan Alt Nöz; Nuriye Ulu; Ayşe Oya Ovünç Kurdaş
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

8.  Efficacy of Helicobacter pylori eradication therapies: a single centre observational study.

Authors:  I L Beales
Journal:  BMC Gastroenterol       Date:  2001-08-10       Impact factor: 3.067

9.  In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.

Authors:  Morris O Makobongo; Leo Einck; Richard M Peek; D Scott Merrell
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

10.  The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H.pylori: a randomized controlled trial.

Authors:  Homayoun Zojaji; Mehdi Ghobakhlou; Hassan Rajabalinia; Elnaz Ataei; Somayeh Jahani Sherafat; Bijan Moghimi-Dehkordi; Rasoul Bahreiny
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.